NVAX today
$9.98-$0.22 (-2.16%)close Nov 11, 2026Trend
DailyUptrend (starting)
4 hourStrong Bearish
1 hourBearish
15 minSymmetric Triangle
5 minStrong Bullish
Daily trend turns down below $7.15
Key levels
Resistance$13.38
Resistance$11.20
Support$9.39
Support$8.30
Latest news & SEC filings
AnalystB. Riley Sets $16 Target for Novavax
AnalystB. Riley Securities keeps Buy rating on Novavax, cuts price target to $16
All NVAX news →About Novavax
Novavax is a biotechnology company that develops vaccines using its recombinant protein nanoparticle technology and Matrix-M adjuvant. Its COVID-19 shot has received regulatory clearances in the United States, Europe, and various other countries, and its adjuvant is a component of a malaria vaccine. The company collaborates with partners such as Sanofi and Pfizer and serves governments and public health organizations globally.
Based on the company's 10-K filed Feb 26, 2026.
Nasdaq · Healthcare
NOVAVAX INC (NVAX)
What Is the Price Target for NVAX?
SEPT Low Target
$8.00
SEPT Mid Target
$11.00
SEPT High Target
$16.00
Analyst Consensus
$11.00
Is NVAX a Buy or Sell Right Now?
Thesis
- •Revenue growing 64.7% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for NVAX.
Start Free Trial →Is NVAX Overvalued or Undervalued?
Valuation Verdict
FAIR
Methods Used
Analyst Consensus
Fair Value
$11.00
17
Moat Score
NONE
5/9
Piotroski Score
-1.9
Altman Z-Score
What Is Smart Money Doing with NVAX?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →NVAX Growth Story
Revenue YoY
64.7%
3yr Revenue CAGR
-17.2%
EPS Growth YoY
309.76%
FCF Growth YoY
N/A%
Revenue Trend
ACCELERATING
Dark Pool Trades for NVAX
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for NVAX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 13:17:33 | $9.88 | 1,194 | $$12K | SELL |
| 13:05:15 | $9.93 | 2,199 | $$22K | SELL |
| 22:03:53 | $9.97 | 1,500 | $$15K | SELL |
| 22:03:39 | $9.97 | 1,500 | $$15K | SELL |
| 21:26:18 | $9.98 | 82,611 | $$824K | SELL |
5 dark pool trades shown · $$888K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for NVAX
PREVIEWSEPT Investing provides real-time options flow tracking for NVAX, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $20 | Jan 15 | 65 | $$10 | 1 | SWEEP |
| CALL | $12 | Nov 13 | 2 | $$2 | 1 | SWEEP |
| CALL | $12 | Nov 13 | 2 | $$2 | 1 | SWEEP |
| CALL | $12 | Nov 13 | 2 | $$2 | 1 | SWEEP |
| CALL | $12 | Nov 13 | 2 | $$2 | 1 | SWEEP |
5 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for NOVAVAX INC (NVAX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →NVAX — frequently asked questions
What is NVAX stock price today?
NOVAVAX INC (NVAX) is at $9.98, down 2.16% (-$0.22) at the Nov 11, 2026 close.
Why is NVAX stock moving today?
Latest NVAX news — Nov 7, 2026: B. Riley Sets $16 Target for Novavax · Nov 6, 2026: B. Riley Securities keeps Buy rating on Novavax, cuts price target to $16
Why did NVAX stock move on Oct 16, 2026?
Novavax shares fell 11.41% on Monday, closing at $11.26 after opening at $12.71 and trading as low as $11.11 on volume of roughly 9.7 million shares. The decline followed news that Shah Capital cut its stake to 6.39%, selling 2.87 million shares at an average price of $11.35, and filed to voluntarily withdraw its registration as an investment adviser with the SEC effective October 16.
What is the NVAX price target?
The average analyst price target for NVAX is $11.00, ranging from $8 to $16, based on 3 analysts.
What do analysts rate NVAX?
Analyst ratings for NVAX: 0 Buy, 5 Hold, 0 Sell — consensus Hold.
Did NVAX beat earnings?
NVAX last reported on Nov 5, 2026: EPS -$0.19 vs -$0.35 expected — a beat of 45.1%.
Does NVAX pay a dividend?
NVAX does not currently pay a dividend.
How much debt does NVAX have?
NOVAVAX INC reported $292M of debt and $222M of cash (Sep 30, 2026).
What are NVAX support and resistance levels?
Support: $9.39, $8.30, $7.15. Resistance: $11.20, $13.38.
What are insiders doing with NVAX?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on NVAX?
Nov 7, 2026: B. Riley Sets $16 Target for Novavax · Nov 6, 2026: B. Riley Securities keeps Buy rating on Novavax, cuts price target to $16